You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽諾醫療(688108.SH):擬出資1億元在蘇州吳中區設立兩家全資子公司
格隆匯 09-23 18:56

格隆匯 9 月 23日丨賽諾醫療(688108.SH)公告,為適應快速變化的市場競爭形勢,促進公司在心腦血管、結構性心臟病等介入治療領域各板塊業務的持續健康發展,完善公司產業鏈及人才佈局,不斷加大公司在醫療器械產業的開拓佈局力度,公司擬使用自有資金合計1億元(人民幣,以下同)在江蘇省蘇州市吳中區設立兩家全資子公司,每家子公司的投資額均為5000萬元,分別從事:(1)結構性心臟病介入醫療器械的研發、生產、銷售;(2)智能製造研發平台、醫療材料研發平台及介入醫療器械領域開發。

2020年8月18日,公司使用自有資金5000萬元在江蘇省蘇州市出資設立“賽諾神暢醫療科技有限公司”,從事神經介入醫療器械的研發、生產及銷售。本次批准設立的兩家子公司設立後,公司12個月內累計對外投資設立子公司金額1.5億元。

截止本公告披露日,該兩家全資子公司尚未設立。該兩家全資子公司的名稱、註冊地、經營範圍等最終以工商行政管理部門核准為準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account